open access

Vol 1, No 6 (2012)
Review articles (submitted)
Published online: 2013-03-11
Get Citation

Gliklazyd MR – skuteczność i poprawa współpracy z pacjentem z cukrzycą typu 2

Bogumił Wolnik
Diabetologia Kliniczna 2012;1(6):239-245.

open access

Vol 1, No 6 (2012)
Review articles (submitted)
Published online: 2013-03-11

Abstract

Type 2 diabetes is a growing problem of modern medicine.
There is an increasing number of evidences that
very good glycemic control is associated with a reduced
risk of micro- and macrovascular long-term complications.
The challenge of today’s diabetology is therefore
the development of such therapeutic regimens that
would secure very good results of metabolic control
for the widest range of patients. In recommended
therapeutic regimens of international organisations, as
well as the Polish Diabetes Association, sulfonylureas
still have a very important position. The special place
among drugs in this group occupies gliclazide MR. This
drug is evaluated as highly effective and very safe,
with a low risk of hypoglycemia. Effi cacy, safety, and
numerous additional benefi cial (pleiotropic) effects of
the drug have been shown in numerous clinical studies.
The advantages of this formulation were fi nely
confi rmed in one of the most major clinical trials conducted
in type 2 diabetes patients — ADVANCE study.
The results of these studies suggest that gliclazide MR
should be taken into account in various therapeutic
regimens in type 2 diabetes patients.

Abstract

Type 2 diabetes is a growing problem of modern medicine.
There is an increasing number of evidences that
very good glycemic control is associated with a reduced
risk of micro- and macrovascular long-term complications.
The challenge of today’s diabetology is therefore
the development of such therapeutic regimens that
would secure very good results of metabolic control
for the widest range of patients. In recommended
therapeutic regimens of international organisations, as
well as the Polish Diabetes Association, sulfonylureas
still have a very important position. The special place
among drugs in this group occupies gliclazide MR. This
drug is evaluated as highly effective and very safe,
with a low risk of hypoglycemia. Effi cacy, safety, and
numerous additional benefi cial (pleiotropic) effects of
the drug have been shown in numerous clinical studies.
The advantages of this formulation were fi nely
confi rmed in one of the most major clinical trials conducted
in type 2 diabetes patients — ADVANCE study.
The results of these studies suggest that gliclazide MR
should be taken into account in various therapeutic
regimens in type 2 diabetes patients.
Get Citation

Keywords

gliclazide MR; gliclazide MR

About this article
Title

Gliklazyd MR – skuteczność i poprawa współpracy z pacjentem z cukrzycą typu 2

Journal

Clinical Diabetology

Issue

Vol 1, No 6 (2012)

Pages

239-245

Published online

2013-03-11

Bibliographic record

Diabetologia Kliniczna 2012;1(6):239-245.

Keywords

gliclazide MR
gliclazide MR

Authors

Bogumił Wolnik

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl